Skip to main content
  • Policy
    Get Involved
    Join BIOAction
    View Advocacy Toolkit
    Patient Advocacy
    Human Health
    Cost and Value of Biopharmaceuticals
    Antimicrobial Resistance
    Vaccines & Biodefense
    Drug Development & Review
    International
    Global Markets & Trade
    Multilateral Organizations
    Intellectual Property
    All Policy
    Patient Advocacy

    Join BIO as we champion for bringing new treatments to patients with serious medical conditions and to support policies that promote innovation and improve patient access.

  • Member
    Membership Options
    Become a BIO Member
    Member Directory
    Have a Voice
    Membership Eligibility
    Member Toolkit
    Benefits By Sector
    member health
    Human Health
    member startups
    Startups
    member non R&D
    Non-R&D Companies
    Member Savings
    BBS-Programs-vwr
    VWR, Part of Avantor
    75% off Lab Supplies
    Save with BIO
    Save with BIO
  • News & Insights
    Latest biotech news
    Popular blogs
    Events
    Policy
    BIO Statements
    Press Releases
    Letters, Testimony & Comments
    Amicus Briefs
    BIO Reports
    Industry Analysis Reports
    Biotech Jobs
    Economic Development Best Practices
    BIO Briefly
    Issue Briefs
    BIO.News
    I am BIO Podcast
    All News & Insights

    Sign up for the BIO.News Newsletter >

  • Events
    Event Portfolio
    Business Development
    Health
    International
    Professional Development
    Members Only
    All Events
    BIO International Convention

    June 22-25, 2026 | San Diego, CA

    Learn More
    BIO Asia-Taiwan
    BIO Europe

    November 3-5, 2025
    Vienna, Austria

    BIO Investor Forum
    Partnering @JPM Week

    January 12-15, 2026
    San Francisco, CA

    BIO Patient & Health Advocacy Summit
    BIO Investment & Growth Summit

    March 2-3, 2026
    Miami, FL

    BIO Webinars

    Explore the webinar opportunities for interactive, online learning about emerging issues in biotechnology public policy, scientific progress, and raising capital, plus methods to benefit from BIO’s membership services.

  • About
    About Us
    Learn about our priorities
    BIO Leadership
    Meet BIO's Senior Leadership and Board of Directors
    Biotech Basics
    Read about biotechnology
    Industry Recognition
    Get to know the outstanding people and companies BIO supports
    Careers @ BIO
    Explore job openings with BIO today
    Diversity & Inclusion >

    Our tools and initiatives on workforce development, diversity and inclusion are designed to advance a more globally competitive industry.

  • Resource Hub
    Latest Resources
    BIO Early-Stage Resources Hub
    BIO Professional Development
    BIO Content Hub
    Biotech News (BIO.News)
    BIO.News Newsletter
    I am BIO Podcast
    BIO Advocacy Toolkit
    Resources Hub
    BIO Early-Stage Resources Hub
    BIO Professional Development
    BIO Webinars
    BIO Microsites
    Clinical Trials: The Power of Participation
    Covid Vaccine Facts
  • Search Results
    Previously Searched
Logo
Logo
Home
Search
  • Policy
    Human HealthPatient AdvocacyInternationalIntellectual PropertyAll Policies
  • Member
    Become a BIO MemberBenefits By Sector
    Human HealthStartupsNon-R&D Companies
    Member DirectoryHave a VoiceMembership EligibilitySavings
  • News & Insights
    Press ReleasesBio.News BlogLetters, Testimony & CommentsAmicus BriefsIndustry Analysis ReportsBiotech JobsEconomic Development Best PracticesIssue BriefsBIO.NewsVideosAll News & Insights
  • Events
    BIO International ConventionBIO Asia-TaiwanAll Events
  • About
    About UsBIO LeadershipDiversity & InclusionBiotech BasicsIndustry RecognitionCareers @ BIO
  • Resource Hub
    Biotech News (BIO.News)BIO.News NewsletterI am BIO PodcastBIO Advocacy ToolkitBIO Early-Stage Resources HubBIO Professional DevelopmentBIO WebinarsClinical Trials: The Power of ParticipationCovid Vaccine Facts
Search Results
Previously Searched
Search Results
Previously Searched
3125 results found
Expand All
Apply All
3125 results found

Lessons from Monkeypox: Are We Prepared for the Next Pandemic?
Share
I am BIO Podcast  •  October 4, 2022
Monkeypox hit our shores in May of this year. How did our public health agencies and infrastructure perform? What went right, what went wrong, and what needs to improve? We talked with three experts in public health and biodefense about the threats on their radar screens and how the U.S. can better prepare for the next inevitable outbreak or pandemic.
Read More
podcast

Implications and Consumer Price Impacts of Mexico's Biotech Corn Ban
Share
Agriculture & Environment  •  Press Release  •  October 3, 2022
Washington, D.C. (October 3, 2022) – Today, a coalition of leading food and agriculture industry stakeholders in both Mexico and the United States released a new study revealing the broad impacts of Mexico’s proposed ban on biotech corn. The report, which was conducted in September 2022 by World Perspectives Inc., reveals that the proposed restrictions would adversely impact food security in North America and raise consumer prices for corn, basic foods, and other critical products derived from corn, particularly in Mexico. Beyond direct commodity impacts, the study shows that banning all biotech corn could affect Mexico’s GDP to the point that it would fall by $11.72 billion over 10 years, and economic output would be reduced by $19.39 billion. Additionally, there would be an annual loss of 56,958 jobs, which would reduce labor income by $2.99 billion. “Like any other North American sector, agriculture must continue to innovate to meet 21st-century challenges. That is why we believe in science-based agricultural policies that improve agricultural production and sustainability,” said Juan Cortina Gallardo, President of the National Agricultural Council of Mexico. “The U.S. - Mexico trading partnership has contributed greatly to the food security and economic vitality of both countries,” said National Corn Growers Association President Chris Edgington. “That’s why we should do everything possible to ensure that the relationship continues in a fair and mutually beneficial way.” Read the full report and executive summary. Should the proposed restrictions be implemented, the study found that the average cost of corn would increase 19% and tortilla prices would rise 16% on average. In the first year of the ban, non-GM corn prices would rise 48% to $8.14/bushel and Mexico would pay an additional $571 million for imported corn. Price increases in corn protein, fiber, oil, and thousands of processed foods distributed by tens of thousands of Mexican food retailers…
Read More

Good Day BIO: Mental illness awareness
Share
Good Day BIO Newsletter  •  October 3, 2022
Treating mental illness requires awareness—the impetus for Mental Health Awareness Week—as well as efforts from biotech. In a sign of the times, Shell is reportedly planning to replace an old oil refinery with a biorefinery making SAFs. (664 words, 3 minutes, 19 seconds)
Read More

Good Day BIO: SBIR passed, PDUFA moves forward
Share
Good Day BIO Newsletter  •  September 30, 2022
Ending the last week before the October recess with a busy day on Capitol Hill, with Congress passing SBIR/STTR yesterday and the continuing resolution with PDUFA expected to pass today. Also, we recap yesterday's Senate hearing on limiting sensitive foreign investment in research. (757 words, 3 minutes, 47 seconds)For your weekend entertainment, remember to listen to the latest I am BIO podcast, "Data Storage Crisis: DNA to the Rescue," on Apple, Google, or Spotify. 
Read More

Coalition Letter to Pres. Biden on High-Level Economic Dialogue with Mexico
Share
Agriculture & Environment, Food & Farm Innovation  •  Letters, Testimony & Comments  •  September 29, 2022
BIO and 24 other organizations call on the Biden Administration to discuss supply chains and food security in future High-Level Economic Dialogue meetings.
Read More

Good Day BIO: Oregon drops plan to limit Accelerated Approval
Share
Good Day BIO Newsletter  •  September 29, 2022
Today, we have good news from Oregon on Accelerated Approval, and what USDA’s doing to advance ag biotech in response to climate change. Meanwhile, we’re awaiting news from Capitol Hill regarding the reauthorization of SBIR/STTIR and PDUFA any moment now, with passage of both expected before the Sept. 30 deadline. (764 words, 3 minutes, 49 seconds)
Read More

BIO Comments on ICH Guidelines: Q2(R2) Validation of Analytical Procedures and Q14 Analytical Procedure Development
Share
Letters, Testimony & Comments  •  September 28, 2022
On Wednesday, September 28th, BIO submitted comments to the Food & Drug Administration on the ICH Q2(R2) Guideline: Validation of Analytical Procedures and the ICH Q14 Guideline: Analytical Procedure Development. In addition to a number of specific line edits, BIO suggested broadly that the ICH Q2(R2) document add further clarity regarding the use of linear and non-linear models, context on use of confidence intervals; and additional examples of modeling techniques and considerations for conducting multivariate analysis. On the Q14 Guideline, BIO encouraged additional language and examples to ensure the Guideline’s applicability for large molecules.
Read More

Good Day BIO: Biden's new food strategy
Share
Good Day BIO Newsletter  •  September 28, 2022
The Biden administration released a food strategy ahead of today’s White House food security conference—we have details and how biotech can help. Plus, how governments are tackling non-communicable diseases and promising news from an Eisai and Biogen Alzheimer’s trial. (635 words, 3 minutes, 10 seconds)
Read More

USDA Role in International Initiatives to Advance Sustainable Productivity Growth and Climate Innovation
Share
Webinars  •  September 28, 2022
In 2021, the United States government launched multiple international initiatives focused on issues at the intersection of climate, agriculture, and sustainable food systems. These initiatives are housed under the U.S. Department of Agriculture (USDA) and involve a cross section of government and non-governmental partners. As part of the 2021 UN Food Systems Summit, the United States launched a Coalition for Sustainable Productivity Growth for Food Security and Resource Conservation (the SPG Coalition) with a goal to accelerate the transition to more sustainable food systems through productivity growth that optimizes agricultural sustainability across social, economic, and environmental dimensions. Agriculture Innovation Mission for Climate (AIM for Climate/AIM4C) is an initiative launched at COP 26 and led by the United Arab Emirates and the United States. AIM for Climate is focused on addressing climate change and global hunger by increasing investment in, and other support for, climate-smart agriculture and food systems innovation over five years (2021–2025) and enabling greater public-private and cross-sectoral partnerships. This webinar hosted by the Biotechnology Innovation Organization (BIO) provides an update on the status of the initiatives including a look ahead to COP 27 and beyond. In addition, USDA staff helping to lead this work discuss ways for private sector partners to engage in, support, and amplify the work of the SPG Coalition and AIM for Climate.
Read More
772148322.png

Good Day BIO: 340B and GM corn
Share
Good Day BIO Newsletter  •  September 27, 2022
We have more on the problems with the 340B program and the growing calls for the U.S. to take action on Mexico's GM corn ban. Plus, work continues on the Continuing Resolution before government funding expires on Friday evening. (671 words, 3 minutes, 21 seconds)And don't forget to listen to the latest I am BIO podcast exploring society's impending data storage problem and how DNA is being used to fix it. Listen now on Apple, Google, and Spotify.
Read More

Pagination

  • First First page
  • Prev Previous page
  • …
  • 127
  • 128
  • 129
  • …
  • Next Next page
  • Last Last page
Biotechnology Innovation Organization
Explore BIO
Policy
Events
About
Industry Insights
Join Now
BIO PAC
For Members
Member Directory
BIO Policy Committees
Cost-Savings Program
BIO Events
BIO International Convention
BIO Partnering at JPM Week
BIO CEO & Investor Conference
BIO Investor Forum
BIO Patient Health & Advocacy Summit
BIO Intellectual Property Counsels Committee Conference
1201 New York Avenue NW, Suite 1300, Washington, DC, 20005 ・ 202-962-9200
© BIO 2025 All Rights Reserved
Privacy Policy
Terms of Use
Contact BIO